Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes.
Rami S KomrokjiLuis E AguirreNajla Al-AliOnyee ChanZhuoer XieAndrew T KuykendallKendra L SweetJeffrey E LancetEric PadronDavid A SallmanPublished in: Blood advances (2023)